Way to Be Active III (Framing Incentives)
- Conditions
- Sedentary Lifestyle
- Registration Number
- NCT02030119
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
Employers are increasingly looking for opportunities to motivate sedentary employees to become more physically active. Workplace walking programs have had mixed success and typically show most improvement among participants that are already fairly active at a baseline. The goal of this study is to determine whether a financial incentive program can motivate sedentary employees to increase the number of steps they walk per day to meet a minimum threshold.
The primary outcome measure is the proportion of days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives. Secondary outcomes will include the average steps walked per day.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 281
- Age greater than 18.
- Participant will need an iPhone or Android smartphone to be able to use the Moves App for tracking steps
- A score of "high" on the International Physical Activity Questionnaire (IPAQ) activity level scale
- BMI less than 27
- Pregnant or lactating
- Participation in another physical activity study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Proportion of Days Each Individual Walks 7000 Steps Per Day or More Throughout the 6 month study The primary outcome measure is the mean proportion of participant-days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives.
- Secondary Outcome Measures
Name Time Method Average Number of Steps Per Day Throughout the 6 month study Secondary outcomes include average number of steps each individual takes per day throughout the 13-week intervention and additional 13-week follow-up periods.
Trial Locations
- Locations (1)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
University of Pennsylvania🇺🇸Philadelphia, Pennsylvania, United States